Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan.

In: Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aboy, M, Crespo, C, Liddell, K, Minssen, T & Liddicoat, J 2019, 'Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine', Nature Biotechnology, vol. 37, pp. 513-518. https://doi.org/10.1038/s41587-019-0111-5

APA

Aboy, M., Crespo, C., Liddell, K., Minssen, T., & Liddicoat, J. (2019). Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nature Biotechnology, 37, 513-518. https://doi.org/10.1038/s41587-019-0111-5

Vancouver

Aboy M, Crespo C, Liddell K, Minssen T, Liddicoat J. Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nature Biotechnology. 2019 May;37:513-518. https://doi.org/10.1038/s41587-019-0111-5

Author

Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen ; Minssen, Timo ; Liddicoat, Johnathan. / Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. In: Nature Biotechnology. 2019 ; Vol. 37. pp. 513-518.

Bibtex

@article{2ac19b960de147ba88632fd4d349a66a,
title = "Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine",
abstract = "On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals.",
keywords = "Faculty of Law, patents, diagnostics, biotechnology, precision medicine, Intellectual property rights (IPR), US, Europe",
author = "Mateo Aboy and Cristina Crespo and Kathleen Liddell and Timo Minssen and Johnathan Liddicoat",
year = "2019",
month = "5",
doi = "10.1038/s41587-019-0111-5",
language = "English",
volume = "37",
pages = "513--518",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine

AU - Aboy, Mateo

AU - Crespo, Cristina

AU - Liddell, Kathleen

AU - Minssen, Timo

AU - Liddicoat, Johnathan

PY - 2019/5

Y1 - 2019/5

N2 - On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals.

AB - On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals.

KW - Faculty of Law

KW - patents

KW - diagnostics

KW - biotechnology

KW - precision medicine

KW - Intellectual property rights (IPR)

KW - US

KW - Europe

UR - https://rdcu.be/bz32p

UR - https://www.nature.com/articles/s41587-019-0111-5

U2 - 10.1038/s41587-019-0111-5

DO - 10.1038/s41587-019-0111-5

M3 - Journal article

C2 - 31053817

VL - 37

SP - 513

EP - 518

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

ER -

ID: 213793676